Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| OncoSynergy | 2026 | Venture - Series Unknown | Undisclosed | Stamford |
| P2 Science | 2026 | Venture - Series Unknown | Undisclosed | Woodbridge |
| Neurosoft Bioelectronics | 2026 | Seed | Undisclosed | Geneva |
| CREW Carbon | 2026 | Series A | $5.3M | Hamden |
| Rally | 2026 | Equity Crowdfunding | Undisclosed | New York |
| VeraDermics | 2026 | Post-IPO Equity | Undisclosed | New Haven |
| Azitra | 2026 | Post Ipo Equity | $31.0M | Branford |
| Inbox Health | 2025 | Venture - Series Unknown | $20.0M | New Haven |
| Revalia Bio | 2025 | Seed | $14.5M | New Haven |
| Oxford Performance Materials | 2025 | Venture - Series Unknown | $355K | South Windsor |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 1 | OncoSynergy | Venture - Series Unknown | Undisclosed | Stamford, United States |
| 2 | P2 Science | Venture - Series Unknown | Undisclosed | Woodbridge, United States |
| 3 | Neurosoft Bioelectronics | Seed | Undisclosed | Geneva, Switzerland |
| 4 | CREW Carbon | Series A | $5.3M | Hamden, United States |
| 5 | Rally | Equity Crowdfunding | Undisclosed | New York, United States |
| 6 | VeraDermics | Post-IPO Equity | Undisclosed | New Haven, United States |
| 7 | Azitra | Post Ipo Equity | $31.0M | Branford, United States |
| 8 | Inbox Health | Venture - Series Unknown | $20.0M | New Haven, United States |
| 9 | Revalia Bio | Seed | $14.5M | New Haven, United States |
| 10 | Oxford Performance Materials | Venture - Series Unknown | $355K | South Windsor, United States |
OncoSynergy improves outcomes for patients with unmet needs in oncology with resistance mechanism inhibitors.
P2 Science produces bio-based chemicals from renewable materials for consumer and industrial use.
Neurosoft Bioelectronics develops minimally invasive brain interfaces to monitor and treat neurological disorders.
CREW Carbon removes CO2 from wastewater using enhanced weathering technology.
Rally is a Mass Mobility Service offering firm that provides technology and model innovations for the business of buses.
VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.
Azitra is a clinical-stage medical dermatology company developing microbiome-based novel therapeutics to treat skin conditions and diseases.
Inbox Health is a digital healthcare company that designs a tool to automate bills and give patients additional insights into their charges.
Launching a new category of pre-clinical research with AI-driven insights from functional human organs in 'Human Data Trials'.
OPM is a commercial company delivering fully functional end-use products to the biomedical, aerospace, and industrial markets.
Intus Bio's Titan-1 platform is powering a microbiome revolution, by unlocking insights into the role of bacteria across health ouctomes
BEKhealth harnesses its AI-powered chart abstraction and patient-matching platform to optimize clinical research enrollment.
PHND is a subscription-free cloud gaming platform for Smart TVs.
Normunity develops precision immuno-oncology medicines that enable normal immunity against cancer.
GoodSAM is a food and beverages company that offers snack and food products made with natural ingredients.
Drowning prevention and aquatic safety platform
Halda Therapeutics is a research-stage drug discovery company.
Conduce Health is an unprecedented healthcare technology company constructed to be a holistic solution for multi-specialty value-based care.
Payer-reimbursed lactation telehealth
Drive action from your data!
Triax Technologies delivers a connected IoT worksite platform for construction, energy, and heavy industrial environments.
Slooh is an astronomy platform that aims to connect humanity through communal exploration of the universe.
Anonybit is a decentralized biometric identification platform that secures biometrics and other digital assets across a host of industries.
CiDRA is a process optimization company that delivers innovative products and services that improves customer's operating performance.
Cytosolix develops novel oral and IV derivatives that target tumor acidity to improve the efficacy of small molecule cancer therapeutics.
Connecticut Innovations has invested in 120 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Connecticut Innovations's top investment sectors include Health Care, Biotechnology, Medical, Therapeutics, Manufacturing. The firm invests across 72 different industry categories.
Among tracked funding rounds, Halda Therapeutics received $126.0M in a Series B round. Connecticut Innovations's total known invested capital is $1.2B.
Connecticut Innovations's average investment size is $13.2M across its portfolio of 120 companies.
Recent Connecticut Innovations portfolio additions include OncoSynergy, P2 Science, Neurosoft Bioelectronics, CREW Carbon, Rally. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors